Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents
- PMID: 22224095
- PMCID: PMC3249774
Synthesis and biological evaluation of bidentate 3-hydroxypyridin-4-ones iron chelating agents
Abstract
A series of 3-hydroxypyridin-4-one derivatives (HPOs) were synthesized and their partition coefficient values (K(part)) were determined. The cytotoxic effects of these iron chelators against Hela cancer cells were also evaluated. The IC(50) of HPOs was determined using MTT assay. Among these ligands, compound 4e (K(part)=5.02) with an IC(50) of 30 μM and 4f (K(part)=0.1) with an IC(50) of 700 μM showed the lowest and highest IC(50)s, respectively. In conclusion, the introduction of a more hydrophobic functional group (such as butyl in compound 4e) on the nitrogen of pyridinone ring resulted in higher cytotoxic activity of ligands.
Keywords: 3-Hydroxypyridin-4-one derivatives; Cytotoxicity; Hela cells; Iron chelators; Partition coefficient.
Figures
Similar articles
-
Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines.Res Pharm Sci. 2013 Jul;8(3):185-95. Res Pharm Sci. 2013. PMID: 24019828 Free PMC article.
-
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.J Biol Chem. 2001 Dec 28;276(52):48814-22. doi: 10.1074/jbc.M109551200. Epub 2001 Oct 15. J Biol Chem. 2001. PMID: 11602611
-
Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.J Med Chem. 1999 Nov 18;42(23):4814-23. doi: 10.1021/jm991080o. J Med Chem. 1999. PMID: 10579844
-
The development of iron chelating drugs.Baillieres Clin Haematol. 1989 Apr;2(2):257-92. doi: 10.1016/s0950-3536(89)80018-6. Baillieres Clin Haematol. 1989. PMID: 2660929 Review.
-
Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.Biometals. 2006 Aug;19(4):349-66. doi: 10.1007/s10534-005-2997-2. Biometals. 2006. PMID: 16841245 Review.
Cited by
-
In vitro antiproliferative study of novel adamantyl pyridin-4-ones.Mol Divers. 2017 Nov;21(4):881-891. doi: 10.1007/s11030-017-9763-6. Epub 2017 Jul 10. Mol Divers. 2017. PMID: 28695468
-
Synthesis, analysis and cytotoxic evaluation of some hydroxypyridinone derivatives on HeLa and K562 cell lines.Res Pharm Sci. 2013 Jul;8(3):185-95. Res Pharm Sci. 2013. PMID: 24019828 Free PMC article.
-
Synthesis and evaluation of the complex-forming ability of hydroxypyranones and hydroxypyridinones with Ni (II) as possible inhibitors for urease enzyme in Helicobacter pylori.Res Pharm Sci. 2016 Jul;11(4):332-42. doi: 10.4103/1735-5362.189319. Res Pharm Sci. 2016. PMID: 27651814 Free PMC article.
-
Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.Curr Med Chem. 2025;32(21):4225-4258. doi: 10.2174/0109298673264118231228042816. Curr Med Chem. 2025. PMID: 40855809 Review.
References
-
- Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford: University Press; 1999. pp. 48–73.
-
- Crichton RR. John Wiley & Sons. 2nd ed. England: Chichester; 2001. Inorganic biochemistry of iron metabolism; pp. 235–243.
-
- Brittenham GM. Disorders of iron metabolism: iron deficiency and iron overload. In: Hoffman R, Benz E, Shatill S, Furie B, Cohen H, editors. Hematology: basic principles and practice. New York: Churchill Livingstone; 2009. pp. 453–468.
-
- Hershko C, Konijin AM, Link G. Iron chelators for thalassaemia. Br J Hematol. 1998;101:399–406. - PubMed
-
- Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu ZD, Hider RC. Synthesis, physicochemical properties and evaluation of N-substituted-2 alkyl-3-hydroxy-4(1H)-pyridinones. J Med Chem. 1998;41:3347–3359. - PubMed
LinkOut - more resources
Full Text Sources